Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalition
Issued Date
2026-01-01
Resource Type
ISSN
12019712
eISSN
18783511
Scopus ID
2-s2.0-105023400535
Pubmed ID
41177443
Journal Title
International Journal of Infectious Diseases
Volume
162
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Infectious Diseases Vol.162 (2026)
Suggested Citation
Rodgers M.A., Averhoff F., Berg M.G., Anderson M., Strobel C., Inostroza J., Moy J., Mera J., Utz P.J., Weaver S.C., Chiu C.Y., De Arcos J.C., Anzinger J.J., Henrys J.H., Hernandez-Ortiz J.P., Torres K., Mendes-Correa M.C., Gonçalves N.J.N., Kallas E., Mboup S., N’jai A.U., Mbanya J.C., de Oliveira T., Kaleebu P., El-Sayed M., Alkhazashvili M., Khan E., Khan R.T., Suputtamongkol Y., Osorio J.E., Cloherty G.A. Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalition. International Journal of Infectious Diseases Vol.162 (2026). doi:10.1016/j.ijid.2025.108162 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/114790
Title
Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalition
Author(s)
Rodgers M.A.
Averhoff F.
Berg M.G.
Anderson M.
Strobel C.
Inostroza J.
Moy J.
Mera J.
Utz P.J.
Weaver S.C.
Chiu C.Y.
De Arcos J.C.
Anzinger J.J.
Henrys J.H.
Hernandez-Ortiz J.P.
Torres K.
Mendes-Correa M.C.
Gonçalves N.J.N.
Kallas E.
Mboup S.
N’jai A.U.
Mbanya J.C.
de Oliveira T.
Kaleebu P.
El-Sayed M.
Alkhazashvili M.
Khan E.
Khan R.T.
Suputtamongkol Y.
Osorio J.E.
Cloherty G.A.
Averhoff F.
Berg M.G.
Anderson M.
Strobel C.
Inostroza J.
Moy J.
Mera J.
Utz P.J.
Weaver S.C.
Chiu C.Y.
De Arcos J.C.
Anzinger J.J.
Henrys J.H.
Hernandez-Ortiz J.P.
Torres K.
Mendes-Correa M.C.
Gonçalves N.J.N.
Kallas E.
Mboup S.
N’jai A.U.
Mbanya J.C.
de Oliveira T.
Kaleebu P.
El-Sayed M.
Alkhazashvili M.
Khan E.
Khan R.T.
Suputtamongkol Y.
Osorio J.E.
Cloherty G.A.
Author's Affiliation
Universidade de São Paulo
University of Wisconsin-Madison
UCSF School of Medicine
Stanford University School of Medicine
Stellenbosch University
John Sealy School of Medicine
Universidad de Guadalajara
The Aga Khan University
Siriraj Hospital
The University of the West Indies
Université de Yaoundé I
Faculty of Medicine, Ain Shams University
Abbott Laboratories
Rush Medical College
Universidad Nacional de Colombia Medellin
Instituto Butantan
Uganda Virus Research Institute
Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
University of Sierra Leone
YR Gaitonde Centre for AIDS Research and Education
Université Quisqueya
DASA
National Center for Disease Control and Public Health
Cherokee Nation Health Services
Institut de Recherche en Santé
University of Wisconsin-Madison
UCSF School of Medicine
Stanford University School of Medicine
Stellenbosch University
John Sealy School of Medicine
Universidad de Guadalajara
The Aga Khan University
Siriraj Hospital
The University of the West Indies
Université de Yaoundé I
Faculty of Medicine, Ain Shams University
Abbott Laboratories
Rush Medical College
Universidad Nacional de Colombia Medellin
Instituto Butantan
Uganda Virus Research Institute
Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
University of Sierra Leone
YR Gaitonde Centre for AIDS Research and Education
Université Quisqueya
DASA
National Center for Disease Control and Public Health
Cherokee Nation Health Services
Institut de Recherche en Santé
Corresponding Author(s)
Other Contributor(s)
Abstract
Objectives Emerging infectious disease outbreaks present a continuous threat globally, and enhanced capacity to detect and mitigate these pathogens is urgently needed. Design The Abbott Pandemic Defense Coalition (APDC) launched in 2021 as a first of its kind global public-private partnership dedicated to early detection, characterization, and response to emerging disease threats with the mission to reduce the burden of existing epidemics and the risk of future pandemics. The APDC has the capacity to both detect emerging infectious agents and respond by rapidly developing and deploying prototype diagnostics to assist in assessing the magnitude of the threat. Results To date, the APDC network, with sites on 5 continents, has evaluated over 39,000 specimens from enrolled patients leading to the identification and characterization of 6 outbreaks and 23 previously unknown viruses that affect humans. The network has also trained 128 scientists in epidemiology, diagnostics, sequencing, and bioinformatics. As a result, the APDC has published 113 manuscripts, which are highlighted herein. Conclusions As emerging pathogens present increasing challenges to public health in a closely connected global community, the APDC is uniquely positioned to continue to serve a key role in pandemic preparedness.